Scholars Central

EditorialPublished 23 Sep 2022

Mouse embryos that have been given histone deacetylase and dna methyltransferase inhibitors

Authors: Mario Niklas

Journal of Systems Biology & Proteome Research

Volume 3 · Issue 5 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Widespread clinical use of the recently approved medications 5-azacitidine and 5-aza-2- deoxyazacytidine is being made to treat all forms of myelodysplastic syndrome as well as chronic myelomonocytic leukaemia. These medications have been tested in randomised clinical trials that show response rates in patients for whom there was no prior standard of care, and they were designed based on an awareness of the significance of epigenetic modifications in malignancy. We are able to target additional chromatin conformation regulators that contribute to aberrant gene transcription and dysregulated cell development as our knowledge of the epigenetic alterations typical of the malignant phenotype advances. One class of medications created utilising this approach is the histone deacetylase inhibitors. Although therapeutic trials utilising HDAC inhibitors in combination with DNA methyltransferase inhibitors have shown promising results, responses using HDAC inhibitors alone in myelodysplastic syndrome have been minimal. Combination therapy gives myelodysplastic patients with previously incurable disease the chance for hematologic improvement and remission. We also give illustrations of how variations in these epigenetic variables impact mouse and human early development. In conclusion, this review offers a synopsis of the most significant epigenetic mechanisms and instances of the tremendous impacts of epigenetic alterations on early mammalian development.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Systems Biology & Proteome Research
  • SubjectMathematics & Statistics
  • BylineArticles whose byline prints “Mario Niklas”